“ Recombinant Factor VIIa Is Associated With an Improved 24-Hour Survival Without an Improvement in Inpatient Survival in Massively Transfused Civilian Trauma Patients ”. Clinics 66, no. 1 (January 1, 2011): 101–106. Accessed May 16, 2024. https://www.revistas.usp.br/clinics/article/view/19460.